Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
INCY	INCYTE CORP	NASDAQ	Biotechnology	$11.66B	$51.92	-0.82%	$919.43M	19.45x	0.31
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$1.67B	$29.35	-0.17%	$221.51M	13.53x	0.74
VYGR	VOYAGER THERAPEUTICS INC	NASDAQ	Biotechnology	$411.06M	$7.57	0.93%	$126.46M	2.46x	0.49
AMLX	AMYLYX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$134.21M	$1.98	5.88%	$55.39M	2.71x	0.19
UTHR	UNITED THERAPEUTICS CORP	NASDAQ	Biotechnology	$11.01B	$234.06	-1.63%	$1.39B	11.12x	0.20
CORT	CORCEPT THERAPEUTICS INC	NASDAQ	Biotechnology	$2.31B	$22.30	-2.83%	$109.00M	21.86x	0.23
EXEL	EXELIXIS INC	NASDAQ	Biotechnology	$6.93B	$22.87	1.55%	$312.21M	35.18x	0.30
PBYI	PUMA BIOTECHNOLOGY INC	NASDAQ	Biotechnology	$249.23M	$5.17	3.19%	$47.52M	11.24x	3.31
MDXG	MIMEDX GROUP INC	NASDAQ	Biotechnology	$934.66M	$6.36	1.11%	$32.57M	15.90x	0.68
HALO	HALOZYME THERAPEUTICS INC	NASDAQ	Biotechnology	$4.91B	$38.71	0.18%	$451.95M	18.17x	19.68
RPRX	ROYALTY PHARMA PLC	NASDAQ	Biotechnology	$16.62B	$27.82	-1.21%	$1.32B	10.95x	0.62
TGTX	TG THERAPEUTICS INC	NASDAQ	Biotechnology	$2.18B	$14.10	2.32%	$25.89M	156.67x	1.05
ROIV	ROIVANT SCIENCES LTD	NASDAQ	Biotechnology	$8.54B	$10.60	1.34%	$4.58B	1.91x	0.12
GMAB	GENMAB A	NASDAQ	Biotechnology	$19.14B	$28.97	0.94%	N/A	29.87x	0.12
MEIP	MEI PHARMA INC	NASDAQ	Biotechnology	$22.45M	$3.37	3.69%	$21.69M	1.13x	0.32
BMRN	BIOMARIN PHARMACEUTICAL INC	NASDAQ	Biotechnology	$16.88B	$89.49	0.97%	$310.28M	100.55x	0.38
BNTX	BIONTECH SE	NASDAQ	Biotechnology	$20.92B	$88.01	1.38%	$1.51B	20.92x	0.14
VNDA	VANDA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$276.18M	$4.80	-6.07%	$9.35M	120.00x	0.19
PLX	PROTALIX BIOTHERAPEUTICS INC	NYSEMKT	Biotechnology	$86.20M	$1.18	2.61%	$11.65M	9.83x	1.52
DBVT	DBV TECHNOLOGIES SA	NASDAQ	Biotechnology	$127.48M	$0.66	-3.08%	-$86.72M	-1.74x	0.31
AVRO	AVROBIO INC	NASDAQ	Biotechnology	$53.83M	$1.20	0.00%	$12.64M	4.44x	0.07
BNOX	BIONOMICS LIMITED	NASDAQ	Biotechnology	$11.09M	$0.96	-1.94%	N/A	0.03x	0.34
SPRO	SPERO THERAPEUTICS INC	NASDAQ	Biotechnology	$75.69M	$1.41	0.36%	$25.77M	3.27x	0.71
KNSA	KINIKSA PHARMACEUTICALS LTD	NASDAQ	Biotechnology	$1.21B	$17.10	1.09%	-$11.26M	85.48x	0.20
CPRX	CATALYST PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.78B	$15.10	-0.20%	$127.65M	22.54x	0.21
KRYS	KRYSTAL BIOTECH INC	NASDAQ	Biotechnology	$4.45B	$157.25	-0.81%	$17.90M	393.13x	0.05
CRSP	CRISPR THERAPEUTICS AG	NASDAQ	Biotechnology	$4.47B	$55.66	1.11%	-$130.89M	-28.69x	0.18
OCUP	OCUPHIRE PHARMA INC	NASDAQ	Biotechnology	$37.47M	$1.51	-8.76%	-$9.97M	-3.28x	0.08
TFFP	TFF PHARMACEUTICALS INC	NASDAQ	Biotechnology	$6.50M	$2.58	-17.04%	-$20.74M	-0.22x	0.26
IGMS	IGM BIOSCIENCES INC	NASDAQ	Biotechnology	$396.81M	$6.75	-6.25%	-$232.05M	-1.43x	1.08
SEER	SEER INC	NASDAQ	Biotechnology	$108.17M	$1.67	0.60%	-$80.49M	-1.24x	0.10
MIRM	MIRUM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.14B	$24.17	1.51%	-$135.87M	-6.04x	1.60
AXSM	AXSOME THERAPEUTICS INC	NASDAQ	Biotechnology	$3.37B	$71.10	4.71%	-$223.54M	-13.49x	2.08
NVO	NOVO NORDISK A S	NYSE	Biotechnology	$564.92B	$125.26	2.08%	$16.66B	46.09x	1.95
ADAG	ADAGENE INC	NASDAQ	Biotechnology	$120.44M	$2.73	3.41%	-$14.94M	-6.25x	0.64
REGN	REGENERON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$98.80B	$900.16	0.37%	$4.69B	24.30x	0.27
FULC	FULCRUM THERAPEUTICS INC	NASDAQ	Biotechnology	$449.03M	$7.25	5.99%	-$95.16M	-4.56x	0.10
IDYA	IDEAYA BIOSCIENCES INC	NASDAQ	Biotechnology	$2.80B	$37.59	1.24%	-$108.95M	-19.18x	0.05
VYNE	VYNE THERAPEUTICS INC	NASDAQ	Biotechnology	$33.13M	$2.35	4.44%	-$28.45M	-0.85x	0.10
VTGN	VISTAGEN THERAPEUTICS INC	NASDAQ	Biotechnology	$129.18M	$4.78	0.42%	-$31.51M	-1.39x	0.06
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	NASDAQ	Biotechnology	$60.24M	$5.26	1.15%	-$6.41M	-8.48x	0.20
IMMP	IMMUTEP LTD	NASDAQ	Biotechnology	$275.81M	$2.32	3.11%	N/A	-9.10x	0.07
AGIO	AGIOS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.70B	$30.21	2.30%	-$334.75M	-4.77x	0.16
RNA	AVIDITY BIOSCIENCES INC	NASDAQ	Biotechnology	$1.93B	$24.16	6.29%	-$207.14M	-8.30x	0.26
JAZZ	JAZZ PHARMACEUTICALS PLC	NASDAQ	Biotechnology	$6.79B	$108.83	-1.01%	$1.22B	16.62x	2.05
TECH	BIO-TECHNE CORP	NASDAQ	Biotechnology	$9.87B	$62.80	1.09%	$372.91M	44.54x	0.39
PRTA	PROTHENA CORP PUBLIC LTD CO	NASDAQ	Biotechnology	$1.14B	$21.29	0.61%	-$152.07M	-7.71x	0.24
ALGS	ALIGOS THERAPEUTICS INC	NASDAQ	Biotechnology	$60.61M	$0.80	6.80%	-$85.06M	-0.59x	0.65
LPCN	LIPOCINE INC	NASDAQ	Biotechnology	$26.95M	$5.07	-3.80%	-$16.32M	-1.64x	0.13
INM	INMED PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.70M	$0.28	-3.45%	-$5.75M	-0.22x	0.19
GNFT	GENFIT SA	NASDAQ	Biotechnology	$182.40M	$3.66	7.33%	-$23.09M	-5.81x	1.56
MDWD	MEDIWOUND LTD	NASDAQ	Biotechnology	$145.34M	$15.76	-0.06%	-$3.34M	-21.01x	1.10
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	NASDAQ	Biotechnology	$728.33M	$27.06	4.16%	-$41.52M	-24.16x	0.54
ORMP	ORAMED PHARMACEUTICALS INC	NASDAQ	Biotechnology	$94.41M	$2.33	2.64%	$7.76M	16.64x	0.35
KZR	KEZAR LIFE SCIENCES INC	NASDAQ	Biotechnology	$59.84M	$0.82	4.05%	-$99.25M	-0.59x	0.18
GBIO	GENERATION BIO CO	NASDAQ	Biotechnology	$186.80M	$2.81	0.36%	-$121.35M	-1.43x	0.85
LIFE	ATYR PHARMA INC	NASDAQ	Biotechnology	$111.11M	$1.64	2.50%	-$47.65M	-1.74x	0.33
ANIX	ANIXA BIOSCIENCES INC	NASDAQ	Biotechnology	$96.02M	$3.01	-3.53%	-$10.70M	-8.85x	0.07
SAGE	SAGE THERAPEUTICS INC	NASDAQ	Biotechnology	$774.78M	$12.89	-3.30%	-$540.10M	-1.42x	0.10
QURE	UNIQURE NV	NASDAQ	Biotechnology	$230.58M	$4.82	3.21%	-$253.10M	-0.74x	3.01
GLPG	GALAPAGOS NV	NASDAQ	Biotechnology	$1.92B	$29.07	-0.03%	$240.55M	8.33x	0.56
PTGX	PROTAGONIST THERAPEUTICS INC	NASDAQ	Biotechnology	$1.55B	$26.61	3.90%	-$75.64M	-19.14x	0.06
LEGN	LEGEND BIOTECH CORP	NASDAQ	Biotechnology	$8.56B	$47.06	1.88%	-$477.87M	-16.01x	0.48
MORF	MORPHIC HOLDING INC	NASDAQ	Biotechnology	$1.43B	$28.50	1.82%	-$150.62M	-7.94x	0.04
ZLAB	ZAI LAB LTD	NASDAQ	Biotechnology	$1.49B	$14.99	6.54%	-$316.88M	-4.28x	0.30
XCUR	EXICURE INC	NASDAQ	Biotechnology	$4.67M	$0.54	-3.74%	$5.04M	0.32x	0.81
NRBO	NEUROBO PHARMACEUTICALS INC	NASDAQ	Biotechnology	$15.31M	$3.12	-7.42%	-$12.46M	-1.27x	0.37
XBIO	XENETIC BIOSCIENCES INC	NASDAQ	Biotechnology	$5.79M	$3.76	-10.48%	-$4.13M	-1.39x	0.08
BOLT	BOLT BIOTHERAPEUTICS INC	NASDAQ	Biotechnology	$42.32M	$1.11	0.00%	-$64.39M	-0.61x	0.42
FATE	FATE THERAPEUTICS INC	NASDAQ	Biotechnology	$474.36M	$4.78	-0.21%	-$142.65M	-2.91x	0.37
MRUS	MERUS NV	NASDAQ	Biotechnology	$2.34B	$40.45	1.61%	-$163.72M	-13.48x	0.28
SNSE	SENSEI BIOTHERAPEUTICS INC	NASDAQ	Biotechnology	$23.34M	$0.93	-4.02%	-$31.25M	-0.76x	0.15
ACIU	AC IMMUNE SA	NASDAQ	Biotechnology	$240.06M	$2.42	2.54%	-$58.90M	-3.33x	0.14
SLGL	SOL-GEL TECHNOLOGIES LTD	NASDAQ	Biotechnology	$26.05M	$0.94	-0.53%	-$26.90M	-0.93x	0.17
ABIO	ARCA BIOPHARMA INC	NASDAQ	Biotechnology	$50.03M	$3.45	1.47%	-$5.23M	-9.32x	0.02
ARGX	ARGENX SE	NASDAQ	Biotechnology	$21.83B	$368.75	2.37%	-$209.00M	-65.74x	0.11
FUSN	FUSION PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.81B	$21.32	0.28%	-$85.08M	-14.70x	0.29
BCYC	BICYCLE THERAPEUTICS PLC	NASDAQ	Biotechnology	$961.17M	$22.57	-3.75%	-$169.40M	-4.44x	0.61
VERV	VERVE THERAPEUTICS INC	NASDAQ	Biotechnology	$577.81M	$6.91	4.07%	-$187.55M	-2.21x	0.26
MRKR	MARKER THERAPEUTICS INC	NASDAQ	Biotechnology	$37.30M	$4.19	1.21%	-$8.23M	-4.46x	0.22
JANX	JANUX THERAPEUTICS INC	NASDAQ	Biotechnology	$2.53B	$48.88	0.39%	-$56.34M	-37.03x	0.11
ZVRA	ZEVRA THERAPEUTICS INC	NASDAQ	Biotechnology	$198.46M	$4.57	1.11%	-$43.54M	-3.52x	1.79
TRAW	TRAWS PHARMA INC	NASDAQ	Biotechnology	$14.12M	$0.67	0.15%	-$18.93M	-0.75x	1.13
EDIT	EDITAS MEDICINE INC	NASDAQ	Biotechnology	$458.16M	$5.60	2.00%	-$164.72M	-2.77x	0.43
CLNN	CLENE INC	NASDAQ	Biotechnology	$42.77M	$0.33	-4.58%	-$42.81M	-0.71x	2.91
ALT	ALTIMMUNE INC	NASDAQ	Biotechnology	$529.59M	$7.47	8.10%	-$87.94M	-4.50x	0.09
SPRB	SPRUCE BIOSCIENCES INC	NASDAQ	Biotechnology	$28.48M	$0.69	-1.14%	-$47.14M	-0.56x	0.36
SPRY	ARS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$792.28M	$8.21	-3.07%	-$54.29M	-14.40x	0.01
PPBT	PURPLE BIOTECH LTD	NASDAQ	Biotechnology	$8.99M	$0.45	-0.44%	$22.27M	N/A	0.29
ARDX	ARDELYX INC	NASDAQ	Biotechnology	$1.51B	$6.51	0.46%	-$55.65M	-21.70x	0.78
BGNE	BEIGENE LTD	NASDAQ	Biotechnology	$13.71B	$130.94	1.10%	-$812.17M	-201.45x	0.64
RVMD	REVOLUTION MEDICINES INC	NASDAQ	Biotechnology	$6.00B	$36.43	4.32%	-$430.28M	-9.44x	0.13
EYPT	EYEPOINT PHARMACEUTICALS INC	NASDAQ	Biotechnology	$844.63M	$16.95	-3.97%	-$69.00M	-9.31x	0.33
SRPT	SAREPTA THERAPEUTICS INC	NASDAQ	Biotechnology	$10.98B	$116.96	1.16%	-$461.21M	-20.17x	2.80
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	NASDAQ	Biotechnology	$16.17M	$0.75	-13.91%	-$1.53M	-1.13x	0.51
ZYME	ZYMEWORKS INC	NASDAQ	Biotechnology	$614.65M	$8.71	-1.58%	-$101.94M	-5.06x	0.25
VRTX	VERTEX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$103.30B	$399.92	1.43%	$4.61B	28.46x	0.29
ITOS	ITEOS THERAPEUTICS INC	NASDAQ	Biotechnology	$386.75M	$10.79	2.18%	-$108.13M	-3.43x	0.16
RYTM	RHYTHM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$2.35B	$39.01	2.63%	-$168.46M	-12.19x	0.96
PLRX	PLIANT THERAPEUTICS INC	NASDAQ	Biotechnology	$759.01M	$12.60	0.64%	-$155.84M	-4.58x	0.08

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -31% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $73.92, an upside of 42.37% from Incyte's current stock price of $51.92.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 25% have issued a Strong Buy rating, 16.67% have issued a Buy, 58.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -9.44% over the past year, overperforming other biotech stocks by 13 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.2% from Harmony Biosciences Holdings's current stock price of $29.35.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock lose -1.69% over the past year, overperforming other biotech stocks by 21 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 170.81% from Voyager Therapeutics's current stock price of $7.57.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 13.74%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 51.93%, which is 38 percentage points higher than the biotech industry average of 13.74%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.1%, which is -13 percentage points lower than the biotech industry average of 13.74%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.85% in the last day, and down -3.62% over the last week. Moolec Science Sa was the among the top gainers in the biotechnology industry, gaining 76.43% yesterday.

Moolec Science shares are trading higher after the company announced that it received USDA approval for plant-grown animal proteins.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -22.36% in the past year. It has overperformed other stocks in the biotech industry by 1 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -1.69% in the past year. It has overperformed other stocks in the biotech industry by 21 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -31% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

48.55% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 88.25% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.21x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.